The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies
Therapeutic Advances in Hematology - United States
doi 10.1177/2040620716681749
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2016
Authors
Publisher
SAGE Publications